Professor of Medical Oncology
0161 446 3606
BM, BA, Bch, FRCP, PhD
Gynaecological medical oncology
Consultant and Chair of Manchester Cancer Systemic Anti-Cancer Therapies Board
Ovarian Cancer, angiogenesis, drug development
Professor Jayson qualified in Medicine at the University of Oxford and then completed his general medical and oncology training in Manchester. Having completed a PhD in heparan sulphate and angiogenesis, he took up a Senior Lecturer position in 1997 at The Christie and The University of Manchester, specialising in ovarian cancer and angiogenic drug development. He has led or written numerous phase I-III ovarian cancer trials. Taking up a Chair in Medical Oncology in 2005, he has served on Cancer Research UK's New Agents Committee, the Medical Research Council's Drug and Device Development Committee and the National Clinical Trials Committee.
Professor Jayson is now Chair of Translational Research for the Medical Research Council ICON7 and chairs Manchester Cancer Systemic Anti-Cancer Therapy Board, developing a strategy for systemic therapy across Manchester. He has written over 190 publications and has attracted tens of millions of pounds of grant income, focusing on ovarian cancer and angiogenic drug development.